(i) Association between csDMARDs and clinical response (∆ASDAS≥1.1) or remission (ASDAS<1.3) at one year, stratified for body mass index; (ii) Flowchart of patients included in the present study. (DOCX 46 kb
Body height before and after correction for kyphosis by using the occiput-to-wall distance. (DOC 118...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Table S1. LSM changes in RAID individual domain scores from baseline to week 24 with sarilumab 200Â ...
Impact of obesity and overweight status on different outcomes after 1Â year of treatment with a firs...
Table S1. Baseline characteristics, subset with inflammatory biomarkers. Table S2. Baseline predicto...
Background: The aim of our study was to investigate the influence of conventional synthetic disease-...
Univariate and multivariate analyses with logistic regression of Objective Response Rate. (DOC 49 kb
Immune-related adverse events of any grade and G3/G4 immune-related adverse events. (DOCX 15 kb
BMI and body fat percentage classification. The supplementary data provides a summary of the sample ...
is a figure showing correlations of BMI with MRI-detected inflammation in inflammatory osteoarthriti...
Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...
is a table presenting the ICC for total inflammation score for 30 arthritis patients scored by all f...
Exploring the associations between systemic inflammation, obesity and healthy days: a health related...
Modified Charlson comorbidity index. Table S1. Other AEs of interest. (PDF 246Â kb
Figure S1. PLS-DA was performed on proteomic data. Figure S2. Overlap between proteins detected in C...
Body height before and after correction for kyphosis by using the occiput-to-wall distance. (DOC 118...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Table S1. LSM changes in RAID individual domain scores from baseline to week 24 with sarilumab 200Â ...
Impact of obesity and overweight status on different outcomes after 1Â year of treatment with a firs...
Table S1. Baseline characteristics, subset with inflammatory biomarkers. Table S2. Baseline predicto...
Background: The aim of our study was to investigate the influence of conventional synthetic disease-...
Univariate and multivariate analyses with logistic regression of Objective Response Rate. (DOC 49 kb
Immune-related adverse events of any grade and G3/G4 immune-related adverse events. (DOCX 15 kb
BMI and body fat percentage classification. The supplementary data provides a summary of the sample ...
is a figure showing correlations of BMI with MRI-detected inflammation in inflammatory osteoarthriti...
Table S1. Prevalence of comorbidities in overweight (Nâ=â14) and obese (12) NAFLD patients. In o...
is a table presenting the ICC for total inflammation score for 30 arthritis patients scored by all f...
Exploring the associations between systemic inflammation, obesity and healthy days: a health related...
Modified Charlson comorbidity index. Table S1. Other AEs of interest. (PDF 246Â kb
Figure S1. PLS-DA was performed on proteomic data. Figure S2. Overlap between proteins detected in C...
Body height before and after correction for kyphosis by using the occiput-to-wall distance. (DOC 118...
Figure S1. The relationship between sdLDL-c/LDL-c ratio and prevalence of MetS. Table S1. Logistic r...
Table S1. LSM changes in RAID individual domain scores from baseline to week 24 with sarilumab 200Â ...